It is evident from the preceding discussion that LpPLA2 may engage with additional risk factors, particularly in individuals experiencing hyperglycemia and hyperlipemia, which together may contribute to the advancement of vascular diseases. The gene discussed is PLA2G7; the disease is familial hyperlipidemia.